Ilios Pharma Private Limited
About Ilios Pharma Private Limited
Data last updated:
Ilios Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2018PTC335293. Its GSTIN is 07AAECI9075Q1ZQ (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prabha Devi Soni and Kamya Verma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 304 Corner T/F Floor Plot No – 1 Harsha Complex Dda Lsc Gazipur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.9 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹72,721 (net margin 1%) and EBITDA of ₹1.23 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 10% over five years.
Company details
Contact details
Ilios Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address304 Corner T/F Floor Plot No – 1 Harsha Complex Dda Lsc Gazipur, New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ilios Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ilios Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ilios Pharma Private Limited, buy the company report.
Financials of Ilios Pharma Private Limited
FY 2025 filings availableIlios Pharma Private Limited reported revenue of ₹70.9 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 10% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹72,721 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ilios Pharma Private Limited, buy the company report.
Board of directors of Ilios Pharma Private Limited
Ilios Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabha Devi Soni | Director | 27 Jul 2018 | 8 Years 2 Months | Current |
| Kamya Verma | Director | 27 Jul 2018 | 8 Years 2 Months | Current |
| Vipin Kumar Also directs: Ekanova Pharmaceuticals Private Limited | Director | 14 Jun 2018 | 8 Years 4 Months | Current |
| Ramjanki Swarnkar | Director | 14 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Ilios Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vishakha Wires Private Limited | ₹70.92 Lakh (FY 2025) | -28.0% | Indore, Madhya Pradesh, India | |||
| Sri Maa Power System Private Limited | ₹70.91 Lakh (FY 2025) | 54.0% | Patna, Bihar, India | |||
| Northern India Chemical Works Private Limited | ₹70.9 Lakh (FY 2025) | -11.0% | Uttar Pradesh, India | |||
| VHN Entity Private Limited | ₹70.9 Lakh (FY 2024) | -42.0% | Kolkata, West Bengal, India | |||
| Paridhan House Private Limited | ₹70.9 Lakh (FY 2021) | -14.0% | Kolkata, West Bengal, India | |||
| Ilios Pharma Private Limitedthis company | ₹70.9 Lakh (FY 2025) | ₹72,721 | 1% | 10.0% | New Delhi, Delhi, India | |
| Way2print Private Limited | ₹70.89 Lakh (FY 2025) | -9.0% | Indore, Madhya Pradesh, India | |||
| Asm Minerals Private Limited | ₹70.89 Lakh (FY 2023) | 11.0% | Delhi, India | |||
| Varahaa Exports India Private Limited | ₹70.88 Lakh (FY 2025) | 39.0% | New Delhi, Delhi, India | |||
| C2b Engineering Private Limited | ₹70.87 Lakh (FY 2025) | 65.0% | Kolkata, West Bengal, India | |||
| I-Sphinx Private Limited | ₹70.84 Lakh (FY 2024) | 433.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Ilios Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ilios Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ilios Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ilios Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECI9075Q1ZQ | Delhi | Active | 30 Oct 2018 |
To see the full GST registrations and return filing status of Ilios Pharma Private Limited, buy the company report.
Recent activity
Ilios Pharma Private Limited has 6 board changes on record since 2018: 5 appointments and 1 cessation. The latest: Vimlesh ceased to be Director on 22 Dec 2018.
Frequently asked questions
Ilios Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2018 (8+ years old) and is registered under CIN U24304DL2018PTC335293.
Ilios Pharma has 4 current directors:
- Prabha Devi Soni - Director
- Kamya Verma - Director
- Vipin Kumar - Director
- Ramjanki Swarnkar - Director
The latest financial statements of Ilios Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ilios Pharma is 07AAECI9075Q1ZQ, registered in Delhi.
The CIN (Corporate Identification Number) of Ilios Pharma is U24304DL2018PTC335293. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ilios Pharma was incorporated on 14 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ilios Pharma by revenue are Vishakha Wires Private Limited, Sri Maa Power System Private Limited, Northern India Chemical Works Private Limited, VHN Entity Private Limited, Paridhan House Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Vimlesh ceased to be Director on 22 Dec 2018. Kamya Verma was appointed as Director on 27 Jul 2018. Prabha Devi Soni was appointed as Director on 27 Jul 2018. Ilios Pharma has 6 board changes on record in total.
The registered office of Ilios Pharma is at 304 Corner TF Floor Plot No – 1 Harsha Complex Dda Lsc Gazipur, New Delhi, Delhi, India – 110092.
Ilios Pharma operates in the pharma industry, in the drug formulation and development segment.
Ilios Pharma can be reached at its registered office: 304 Corner TF Floor Plot No – 1 Harsha Complex Dda Lsc Gazipur, New Delhi, Delhi, India – 110092.